Most supplements make vague promises. Triphala is different. For over a millennium, Ayurvedic physicians have prescribed this three-fruit formula for digestive health, longevity, and systemic balance. What once seemed like ancient wisdom is now backed by hundreds of peer-reviewed scientific studies showing real, measurable benefits.
If you struggle with digestion, want to understand what your body actually needs, or simply feel curious about why traditional medicine has valued this particular remedy for so long, this article answers your questions completely.
What is Triphala, Really?
Triphala translates from Sanskrit as "three fruits." That's exactly what it is: a precise blend of three dried fruits in equal proportions, each bringing distinct medicinal properties that work together synergistically.1
The three fruits are:
- Amalaki (Phyllanthus emblica), also called Indian gooseberry: Rich in vitamin C and tannins; your primary source of antioxidant power
- Bibhitaki (Terminalia bellerica), also called beleric myrobalan, contains lignins and flavonoids; it contributes astringent and metabolic-supporting properties
- Haritaki (Terminalia chebula), also called chebulic myrobalan, contains polyphenolic compounds and gallic acid; it provides mild laxative properties
Think of it as nature's supplement cocktail: three different fruits, each with its own healing profile, combined to address multiple health systems simultaneously.1
Triphala has been used continuously in Ayurvedic medicine for over 1,000 years. It appears in foundational Ayurvedic texts like the Charaka Samhita, where ancient physicians classified it as a "Rasayana": a rejuvenating tonic designed to promote longevity and overall wellness rather than treat a single disease.2
What's remarkable is that modern science has now validated much of this traditional use. When researchers test Triphala in clinical trials, they consistently find the benefits that Ayurvedic doctors have been describing for centuries.
Figure 1: The classical 1:1:1 composition of Triphala has remained consistent for centuries, combining equal parts of three fruits for synergistic effects.
Why Digestive Health is Its Strongest Claim
The most scientifically validated use of Triphala is treating constipation and digestive dysfunction. Unlike harsh chemical laxatives, Triphala works through multiple gentle mechanisms simultaneously.
The Dramatic Bowel Movement Improvement
Here's what happens to people taking Triphala for constipation. One clinical trial tracked people with functional constipation (meaning chronic, difficult bowel movements without an underlying disease). At the start, they averaged 10 bowel movements per week. After just 14 days of Triphala, this nearly doubled to 18 movements per week; this represents a 79.5% increase.3
That's not a modest improvement. That's the difference between struggling and feeling normal.
But it's not just about frequency. The quality of those bowel movements improved dramatically too. The Bristol Stool Form Scale (the actual clinical measure doctors use to assess stool consistency) improved from 2.97 at baseline to 4.61 within two weeks, moving from hard, difficult stools towards healthy, normal bowel movements.3
Beyond that, patients reported relief from:
- Straining during bowel movements
- Sensation of incomplete evacuation
- Bloating and flatulence
- Abdominal pain and discomfort
Figure 2: Clinical data shows Triphala increases weekly bowel movements by nearly 80% within 14 days, with improvements in stool consistency alongside the frequency increase.
Why It Works: Gentle Rather Than Forceful
Most laxatives work by irritating your intestines to force defecation. Triphala is fundamentally different. It functions as a mild laxative at normal doses and a bowel tonic at lower doses.4
This means something remarkable happens: Triphala can help both constipation AND diarrhoea. Researchers found it demonstrated "remarkable anti-diarrhoeal activity" against induced diarrhoea in animal models.5 This dual action works because Triphala operates through multiple mechanisms rather than simply forcing movement. It:
- Promotes intestinal motility through its tannin content
- Restores the integrity of intestinal epithelial cells (the lining of your gut)
- Functions as a mild irritant that encourages normal defecation without causing damage
- Acts as a prebiotic, promoting beneficial bacteria
This adaptability is why Ayurvedic doctors preferred Triphala to single-action laxatives. Your body gets what it needs, not just one directional effect.
The Science Behind Multiple Health Benefits
Triphala's traditional use extended far beyond digestive health. Modern research now explains why this formula addresses so many different systems.
Antioxidant Power: Supercharging Your Cells' Defence Systems
Your cells produce natural enzymes that protect against free radical damage. These enzymes (superoxide dismutase, catalase, glutathione peroxidase, and others) are your cellular cleanup crew.
In studies using arthritic rat models (where inflammation and oxidative stress run high), Triphala dramatically increased these protective enzymes:6
- Glutathione S-transferase increased 82.1%
- Superoxide dismutase increased 75.6%
- Reduced glutathione increased 72.7%
- Catalase increased 62.7%
- Glutathione peroxidase increased 55.8%
To translate this into human terms: Triphala essentially supercharged the body's built-in antioxidant defences by 55-82%. Think of it as upgrading your cellular protection system.6
Beyond enzyme production, Triphala also directly neutralises free radicals through its polyphenol content. These compounds (gallic acid, ellagic acid, punicalagin, and 14+ other identified compounds) actively scavenge harmful free radicals before they can damage cells.1
Importantly, Triphala is chemically complex. It contains 14+ distinct bioactive compounds working simultaneously through different mechanisms. This complexity is actually beneficial: pathogens and cancer cells can develop resistance to single-molecule drugs, but multiple compounds attacking through different pathways are far harder to resist.1
Figure 3: Laboratory studies show Triphala increases all major antioxidant defence enzymes by 55-82% in arthritic models, providing multiple layers of cellular protection.
Anti-inflammatory Effects: Turning Down the Body's Inflammation Switch
Chronic inflammation underlies most modern diseases: heart disease, arthritis, Alzheimer's, cancer, and obesity. Your cells have a master control switch called NF-κB that turns inflammatory cascades on and off. Triphala appears to inhibit this inflammatory pathway.6
Specifically, researchers found that Triphala:
- Suppresses NF-κB p65 protein expression (the active form of the inflammation switch)
- Reduces pro-inflammatory cytokines (TNFα and IL-17)
- Decreases expression of inflammatory enzymes (iNOS and COX-2)
In rat arthritis models, Triphala reduced inflammatory markers as effectively as standard anti-inflammatory treatments.6
Important note: The strongest anti-inflammatory evidence comes from animal studies and laboratory models. Human clinical trials for inflammatory conditions are more limited, though preliminary post-COVID data shows promise for reducing systemic inflammation.7 This is an area where the evidence is compelling but not yet complete.
Oral Health: A Natural Alternative to Prescription Rinses
Gingivitis (gum inflammation) and periodontal disease affect millions of people. The standard treatment has been chlorhexidine mouthwash: a prescription-strength antimicrobial that works very well but has significant side effects including tooth staining, bitter taste, and tissue irritation.
Researchers wondered whether Triphala could offer an alternative. What they found was striking.
Comparable to Prescription Mouthwash, Without the Side Effects
In a randomised clinical trial with proper controls, Triphala mouthwash demonstrated clinically equivalent efficacy to 0.2% chlorhexidine mouthwash.8 It reduced gingival inflammation, prevented plaque accumulation, and killed cavity-causing bacteria just as effectively as the prescription alternative.
But here's the crucial difference: Triphala did this without chlorhexidine's side effects. Patients tolerated it significantly better. It's also more cost-effective.9
The mechanism involves multiple actions:
- Plaque reduction: Randomised controlled trials with meta-analysis support show significant plaque reduction10
- Bacterial killing: The combination of all three fruits in Triphala proved more effective against cavity-causing bacteria (mutans streptococci) than any individual fruit alone11
- Gingival inflammation reduction: Multiple trials documented significant reductions in gum swelling and inflammation12
For people with gingivitis, this matters enormously. It offers evidence-based treatment with better tolerability and lower cost than prescription options.
Immune System Support: Multiple Immune Cell Enhancement
Your immune system has multiple players: helper T cells, killer T cells, natural killer cells, and neutrophils. They work together to fight infection and eliminate cancerous cells.
In a clinical Phase I trial, healthy volunteers took 1,050 mg of Triphala daily for several weeks. Researchers measured specific immune markers before and after. The results showed:
- Significant increase in cytotoxic T lymphocytes (CD8+ cells): These are your "killer" immune cells that destroy infected or cancerous cells13
- Significant increase in natural killer cells (CD16+CD56+ cells): These patrol for abnormal cells and viral infections13
- Enhanced neutrophil function: Neutrophils became more aggressive at killing bacteria without disrupting hormone balance14
- Stress-induced immune protection: Triphala prevented the typical immune suppression that occurs under psychological stress, maintaining protective cytokine levels (IL-2 and IFN-γ) while preventing excessive IL-4 elevation15
Importantly, no adverse effects were detected at this dosage.13
Context on this evidence: Phase I trials are initial safety and feasibility studies with smaller sample sizes. They're not definitive proof of efficacy. Larger Phase II and III trials would be needed to establish optimal dosing and determine whether these effects translate into real-world benefits like fewer infections or better cancer outcomes. The data is promising but preliminary.
Figure 4: Phase I clinical trial data show Triphala significantly increases multiple immune cell types simultaneously, suggesting potential benefits during periods of immune stress or aging.
Metabolic Health: Lipid and Glucose Management
The evidence for Triphala's effects on cholesterol and blood sugar is more mixed than for digestive health, but several mechanisms appear to work.
Blood Sugar Control
In patients with type 2 diabetes (non-insulin-dependent), taking 5 grams of Triphala daily for 45 days significantly reduced blood glucose levels, measured on days 14 and 35 of treatment.16 The mechanism appears to involve enhanced insulin secretion and improved glucose uptake by cells.
For someone with uncontrolled type 2 diabetes, this represents a meaningful benefit. However, Triphala should be viewed as complementary to, not a replacement for, standard diabetes medications. Anyone with diabetes should work with their healthcare provider to determine if Triphala fits into their treatment plan.
Cholesterol and Triglycerides
The cholesterol data is more complicated. Different studies show different results. Across 12 systematic review studies involving 749 total patients:
- LDL cholesterol (the harmful type): Significantly reduced in 6 out of 12 studies17
- Total cholesterol: Reduced in multiple studies, with one randomised trial showing a 3.3% reduction versus 1.9% in the placebo group18
- HDL cholesterol (the protective type): Significantly improved on day 35 of supplementation at 2,500 mg daily17
- Triglycerides: Significantly reduced in animal and human studies17
The takeaway? Triphala shows modest benefits for lipid profiles, particularly when combined with dietary changes. But these improvements are not as consistent or dramatic as standard statin therapy. If you have elevated cholesterol, Triphala might be a useful complementary approach, but it shouldn't replace prescribed statin therapy.
How to Use Triphala: Forms, Dosages, and Practical Guidance
What Forms Are Available?
Powder (Churna) The traditional form. Mix 1-2 grams in 200 mL of water. It's cost-effective but requires mixing. Quality varies between manufacturers, so choose reputable brands.
Capsules Most convenient. Typically, 500 mg capsules; clinical trials often used 5 capsules (2,500 mg) taken once daily, usually at bedtime. Consistent dosing makes this ideal for most people.
Tablets made with compressible excipients; standardised using HPLC methods. Note that tablets contain approximately 4-fold higher manganese than powder forms, which may matter for some people.
Water Decoction The traditional preparation: steep the powder in hot water, then filter. Equally effective as commercial formulations and economical. This form proved as effective as commercial mouthwash when used for oral health.
Recommended Dosages
The safe dosage range established through clinical trials is 1 to 2.5 grams daily.19
|
Use Case |
Dose |
Timing |
Duration |
|
Constipation management |
2-2.5 g |
Bedtime |
Daily, ongoing |
|
Digestive support |
1-2 g |
Morning or bedtime |
Daily |
|
Metabolic support |
5 g |
Single dose |
45 days (study protocol) |
|
General wellness |
1-1.5 g |
Daily, flexible |
Long-term |
|
Immune support (Phase I study) |
1,050 mg (approximately 1 g) |
Daily |
Multiple weeks |
Clinical trials used a 2,500 mg daily dose (5 capsules of 500 mg) for up to 28 days with no serious adverse effects.19 Higher doses have been tested safely in animal studies, but the 1-2.5 gram range is well-established for human use.
Figure 5: Established safe dosage ranges from clinical trials, showing that traditional Thai dosing (1 g every 4 hours) and clinical study dosages (5 g daily) both fall well within safety limits.
Practical Tips for Home Use
- Start low, go slow: Begin with 1 gram daily to assess individual tolerance, then increase if needed
- Take with water: Dissolve powder in 200 mL of water or take capsules with a full glass of water for optimal absorption
- Evening timing: Many clinical studies used bedtime dosing, which may be helpful for digestive effects
- Consistency matters: Regular daily use showed benefits in clinical trials; episodic use isn't well-studied
- Quality varies: Check for reputable manufacturers with third-party testing; Triphala composition varies significantly between brands
- Store properly: Keep powder in a cool, dry place; check expiration dates
Safety Profile: What Research Actually Shows
This is where Triphala's evidence becomes genuinely impressive. The safety data across human clinical trials is exceptional.
The Remarkable Safety Record
Across 12 randomised controlled trials involving 749 total patients, zero serious adverse events were reported.20
To put this in perspective: common over-the-counter pain relievers like ibuprofen cause serious adverse events in approximately 1-3% of long-term users. Triphala's safety profile is demonstrably better than many supplements people take without a second thought.
The only notable adverse effect was mild: in one clinical trial, 4.3% of participants (2 out of 47) experienced a hypersensitivity rash, compared to 0% in the placebo group.19 This is rare, mild, and non-serious.
What Toxicity Testing Revealed
Researchers tested Triphala at doses far exceeding what any human would take:
- Acute toxicity: Safe up to 1,750 mg/kg in acute toxicity testing (following OECD guidelines)20
- Chronic toxicity: No toxic effects observed at doses of 600, 1,200, and 2,400 mg/kg/day for 270 days in rats20
- No organ damage: No changes in liver function, kidney function, or blood parameters in animals or humans
This extensive testing establishes a wide margin of safety above recommended human doses.
Minor Laboratory Changes (Without Clinical Significance)
Some preclinical studies noted minor alterations in blood glucose, blood urea nitrogen, red blood cell counts, and related parameters. However, tissue examination (histopathology) showed no actual damage.20 Lab value changes without tissue damage typically don't concern clinicians; it's why doctors distinguish between "abnormal lab value" and "clinically significant abnormality."
Figure 6: Clinical safety data from 12 randomised controlled trials shows zero serious adverse events in 749 patients and only 4.3% mild hypersensitivity reactions, establishing an exceptional safety profile.
Important Cautions and Drug Interactions
Whilst Triphala's safety profile is excellent at recommended dosages, certain situations require caution.
Cytochrome P450 Enzyme Interactions
Your liver metabolises most medications using enzymes called cytochrome P450 isoforms. Triphala inhibits several of these enzymes, particularly:
- CYP1A2 (strongest inhibition)
- CYP3A4
- CYP2C9
- CYP2D6 (weakest inhibition)
This inhibition is primarily reversible (temporary), not permanent.21
In animal studies, when rats received Triphala alongside certain medications, the medications' blood levels increased, suggesting slower metabolism.21 This could theoretically increase drug effects or toxicity.
Important context: Despite this inhibition in laboratory settings, no clinically significant drug interactions have been documented in human studies. This is a good reminder that what happens in test tubes and animal studies doesn't always translate to human bodies. Real-world clinical experience trumps theoretical risk.
However, caution remains warranted for certain medications metabolised by these enzymes, particularly opioids, benzodiazepines, and other drugs with narrow therapeutic windows.
Who Should Consult a Healthcare Provider First
Before starting Triphala, speak with your doctor if you:
- Take prescription medications (most common drugs are metabolised by CYP450 enzymes)
- Have liver disease or impaired liver function
- Take blood sugar-lowering medications (Triphala reduces blood glucose)
- Have bleeding disorders or take anticoagulant therapy (blood thinners)
- Are pregnant or nursing (specific safety data is limited)
- Have severe gastrointestinal conditions
- Have a known hypersensitivity to any Triphala component
This isn't because Triphala is dangerous: it's standard medical practice before introducing any supplement, especially one that affects how your body processes medications.
When to Stop and Seek Medical Attention
Discontinue use and contact your healthcare provider if you experience:
- Allergic reaction signs: rash, itching, difficulty breathing, or facial swelling
- Persistent diarrhoea or severe abdominal pain
- Signs of liver problems: yellowing of skin or eyes, dark urine, or abdominal pain
- Unusual bleeding or bruising
- Severe hypoglycaemia (if you have diabetes)
- Any unexpected symptoms after starting Triphala
Understanding the Research Limitations
Triphala has been studied extensively, but important research gaps remain. Understanding these helps you evaluate the evidence fairly.
Areas with Strong Human Clinical Evidence
- Digestive health and constipation: Multiple randomised controlled trials with clear outcome measures
- Oral and dental health: Randomised controlled trials with proper controls; meta-analysis available
- Safety profile: Extensive data across 749 patients in 12 trials
Areas with Moderate Evidence (Animal Studies + Limited Human Data)
- Antioxidant enzyme improvement: Strong in animal models; limited human data
- Anti-inflammatory effects: Strong in animal arthritis models; limited human trials
- Immune system support: Phase I clinical evidence; larger Phase II/III trials needed
- Lipid and glucose management: Mixed human results; more consistent in animal studies
- Wound healing: Good laboratory and animal evidence; limited human clinical data
Areas with Preliminary Evidence (Early Studies Only)
- Cognitive and mental health benefits: Emerging research; more rigorous trials needed
- Diabetic neuropathy treatment: Animal studies show promise; human trials lacking
- Post-COVID symptom reduction: Very preliminary; larger studies needed
Key Research Gaps
- Limited long-term data: Most studies track outcomes for weeks to months; long-term safety and efficacy data beyond one year are limited
- Bioavailability concerns: Triphala's polyphenols face challenges crossing the blood-brain barrier; systemic bioavailability needs improvement
- Dose standardisation: Variation in Triphala formulations, extraction methods, and constituent ratios across studies makes comparisons difficult
- Publication bias: Positive results are more likely to be published; negative or null findings may be underrepresented
This matters because it means Triphala's most solid evidence applies to digestive and oral health. For other claimed benefits, you're relying on animal studies and laboratory data; this is promising but not yet definitive in humans.
Figure 7: Evidence strength varies across different applications, with strongest support for digestive and oral health, moderate support for immune and metabolic effects, and preliminary evidence for cognitive benefits.
The Bottom Line: What You Actually Need to Know
Triphala is a well-tolerated herbal formulation with genuine scientific support for specific uses.
Use it confidently for:
- Constipation and digestive dysfunction (strongest evidence)
- Oral health and gingivitis (multiple clinical trials, comparable to prescription options)
Consider it supportively for:
- General antioxidant and anti-inflammatory support (strong laboratory evidence, limited human trials)
- Immune system enhancement (Phase I evidence shows promise, but larger trials needed)
- Metabolic health support (modest benefits for cholesterol and blood sugar, not a replacement for medications)
Approach with caution pending more research:
- Cognitive or mental health claims (very preliminary evidence)
- Cancer prevention or treatment (only preclinical evidence)
- Weight loss (animal studies only, no human data)
The 1,000-year track record matters. Triphala has been continuously used and refined by thousands of practitioners over centuries. Combined with modern clinical validation, this gives genuine confidence in its safety and fundamental effectiveness. But it also means you're using a traditional remedy, not a pharmaceutical drug with years of controlled marketing and advertising behind it.
Triphala won't magically solve your health problems. But if you struggle with constipation, want a natural approach to oral health, or seek a well-tolerated supplement with exceptional safety data, the evidence genuinely supports its use.
Further Reading
Digestive Health and Constipation Management
- Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders
- An open-label, prospective clinical study to evaluate the efficacy and safety of Triphala in the management of functional constipation
- Evaluation of anti-diarrhoeal property and acute toxicity of Triphala Mashi
Oral Health and Dental Care
- A randomised clinical trial to evaluate and compare the efficacy of Triphala mouthwash with chlorhexidine
- Effect of Triphala mouthrinse on plaque and gingival inflammation: A systematic review and meta-analysis
- Assessment of antibacterial efficacy of Triphala against mutans streptococci
Antioxidant and Anti-inflammatory Effects
- Triphala herbal extract suppresses inflammatory responses in macrophages and arthritic rats via NF-κB pathway inhibition
- The anti-inflammatory effect of Triphala in arthritic-induced rats
- Ameliorative Effects of Triphala on Oxidative Stress and Inflammation in Post-COVID-19 Condition
Immune System Support
- Significant Increase in Cytotoxic T Lymphocytes and Natural Killer Cells by Triphala: A Clinical Phase I Study
- Immunomodulatory activity of Triphala on neutrophil functions
- Insights into the potential benefits of Triphala polyphenols toward resilience against stress-induced depression
Metabolic Health and Lipid Management
- Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review
- Determination of chemical composition and investigation of Triphala in hypercholesterolaemia
- Triphala and its constituents ameliorate visceral adiposity from high-fat diet
.Safety and Clinical Evidence
- Safety of the Oral Triphala Recipe from Acute and Chronic Toxicity Tests
- Study of the safety of oral Triphala aqueous extract on healthy volunteers
- Therapeutic Uses of Triphala in Ayurvedic Medicine
Composition and Mechanisms of Action
- Triphala's characteristics and potential therapeutic uses in modern health
- Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a review
- Modulatory Effects of Triphala on Human Gut Microbiota
References/Helpful Resources
- Peterson CT, Denniston K, Chopra D. Therapeutic Uses of Triphala in Ayurvedic Medicine. J Altern Complement Med. 2017 Aug;23(8):607-614. doi: 10.1089/acm. 2017.0083. Epub 2017 Jul 11. PMID: 28696777; PMCID: PMC5567597.
- Bairwa VK, Kashyap AK, Meena P, Jain BP. Triphala's characteristics and potential therapeutic uses in modern health. Int J Physiol Pathophysiol Pharmacol. 2025 Apr 25;17(2):19-36. doi: 10.62347/OBSS5026. PMID: 40401115; PMCID: PMC12089839.
- Munshi R, Bhalerao S, Rathi P, Kuber VV, Nipanikar SU, Kadbhane KP. An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation. J Ayurveda Integr Med. 2011 Jul;2(3):144-52. doi: 10.4103/0975-9476.85554. PMID: 22022157; PMCID: PMC3193686.
- Biradar YS, Singh R, Sharma K, Dhalwal K, Bodhankar SL, Khandelwal KR. Evaluation of anti-diarrhoeal property and acute toxicity of Triphala Mashi, an Ayurvedic formulation. J Herb Pharmacother. 2007;7(3-4):203-12. doi: 10.1080/15228940802152869. PMID: 18928142.
- Tarasiuk A, Mosińska P, Fichna J. Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders. Chin Med. 2018 Jul 18;13:39. doi: 10.1186/s13020-018-0197-6. PMID: 30034512; PMCID: PMC6052535.
- Kalaiselvan S, Rasool MK. Triphala herbal extract suppresses inflammatory responses in LPS-stimulated RAW 264.7 macrophages and adjuvant-induced arthritic rats via inhibition of NF-κB pathway. J Immunotoxicol. 2016 Jul;13(4):509-25. doi: 10.3109/1547691X.2015.1136010. Epub 2016 Jul 20. PMID: 27438966.
- Intakhiao S, Prakobkaew N, Buddhisa S, Boonla O, Teethaisong Y, Koowattanatianchai S, Prasertsri P. Ameliorative Effects of Triphala Supplementation on Oxidative Stress and Inflammation in Individuals with Post-COVID-19 Condition: A Preliminary Randomized Controlled Trial. Glob Adv Integr Med Health. 2025 Oct 15;14:27536130251385551. doi: 10.1177/27536130251385551. PMID: 41122087; PMCID: PMC12536147.
- Naiktari RS, Gaonkar P, Gurav AN, Khiste SV. A randomized clinical trial to evaluate and compare the efficacy of triphala mouthwash with 0.2% chlorhexidine in hospitalized patients with periodontal diseases. J Periodontal Implant Sci. 2014 Jun;44(3):134-40. doi: 10.5051/jpis.2014.44.3.134. Epub 2014 Jun 5. PMID: 24921057; PMCID: PMC4050230.
- Mamgain P, Kandwal A, Mamgain RK. Comparative Evaluation of Triphala and Ela Decoction With 0.2% Chlorhexidine as Mouthwash in the Treatment of Plaque-Induced Gingivitis and Halitosis: A Randomized Controlled Clinical Trial. J Evid Based Complementary Altern Med. 2017 Jul;22(3):468-472. doi: 10.1177/2156587216679532. Epub 2016 Dec 8. PMID: 27932522; PMCID: PMC5871163.
- AlJameel AH, Almalki SA. Effect of triphala mouthrinse on plaque and gingival inflammation: A systematic review and meta-analysis of randomized controlled trials. Int J Dent Hyg. 2020 Nov;18(4):344-351. doi: 10.1111/idh.12444. Epub 2020 May 20. PMID: 32383334.
- Srinagesh J, Pushpanjali K. Assessment of antibacterial efficacy of triphala against mutans streptococci: a randomised control trial. Oral Health Prev Dent. 2011;9(4):387-93. PMID: 22238738.
- Pradeep AR, Suke DK, Martande SS, Singh SP, Nagpal K, Naik SB. Triphala, a New Herbal Mouthwash for the Treatment of Gingivitis: A Randomized Controlled Clinical Trial. J Periodontol. 2016 Nov;87(11):1352-1359. doi: 10.1902/jop.2016.130406. Epub 2016 Jul 21. PMID: 27442086.
- Phetkate P, Kummalue T, U-Pratya Y, Kietinun S. Significant increase in cytotoxic T lymphocytes and natural killer cells by triphala: a clinical phase I study. Evid Based Complement Alternat Med. 2012;2012:239856. doi: 10.1155/2012/239856. Epub 2012 Dec 2. PMID: 23243435; PMCID: PMC3519011.
- Srikumar R, Jeya Parthasarathy N, Sheela Devi R. Immunomodulatory activity of triphala on neutrophil functions. Biol Pharm Bull. 2005 Aug;28(8):1398-403. doi: 10.1248/bpb.28.1398. PMID: 16079482.
- Wang W, Ige OO, Ding Y, He M, Long P, Wang S, Zhang Y, Wen X. Insights into the potential benefits of triphala polyphenols toward the promotion of resilience against stress-induced depression and cognitive impairment. Curr Res Food Sci. 2023 Jun 2;6:100527. doi: 10.1016/j.crfs.2023.100527. PMID: 37377497; PMCID: PMC10291000.
- Phimarn W, Sungthong B, Itabe H. Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review. J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211011038. doi: 10.1177/2515690X211011038. PMID: 33886393; PMCID: PMC8072855.
- Phimarn W, Sungthong B, Itabe H. Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review. J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211011038. doi: 10.1177/2515690X211011038. PMID: 33886393; PMCID: PMC8072855.
- Donato F, Raffetti E, Toninelli G, Festa A, Scarcella C, Castellano M; TRIGU Project Working Group. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial. Complement Med Res. 2021;28(3):216-225. English. doi: 10.1159/000510985. Epub 2020 Nov 26. PMID: 33242870.
- Phetkate P, Kummalue T, Rinthong PO, Kietinun S, Sriyakul K. Study of the safety of oral Triphala aqueous extract on healthy volunteers. J Integr Med. 2020 Jan;18(1):35-40. doi: 10.1016/j.joim.2019.10.002. Epub 2019 Oct 16. PMID: 31680053.
- Arpornchayanon W, Subhawa S, Jaijoy K, Lertprasertsuk N, Soonthornchareonnon N, Sireeratawong S. Safety of the Oral Triphala Recipe from Acute and Chronic Toxicity Tests in Sprague-Dawley Rats. Toxics. 2022 Aug 30;10(9):514. doi: 10.3390/toxics10090514. PMID: 36136479; PMCID: PMC9503284.
- Nontakham J, Siripong P, Sato H, Chewchinda S, Arunrungvichian K, Yahuafai J, Goli AS, Sato VH. Inhibitory effects of Triphala on CYP isoforms in vitro and its pharmacokinetic interactions with phenacetin and midazolam in rats. Heliyon. 2022 Jun 20;8(6):e09764. doi: 10.1016/j.heliyon.2022.e09764. PMID: 35785236; PMCID: PMC9243172

